Cargando…
Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells
Therapeutic glycoproteins have played a major role in the commercial success of biotechnology in the post-genomic era. But isolating recombinant mammalian cell lines for large-scale production remains costly and time-consuming, due to substantial variation and unpredictable stability of expression a...
Autores principales: | Pilbrough, Warren, Munro, Trent P., Gray, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793030/ https://www.ncbi.nlm.nih.gov/pubmed/20037651 http://dx.doi.org/10.1371/journal.pone.0008432 |
Ejemplares similares
-
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia
por: Beke, Allan, et al.
Publicado: (2020) -
Estimating intraclonal heterogeneity and subpopulation changes from bulk expression profiles in CMap
por: Hsieh, Chiao-Yu, et al.
Publicado: (2022) -
Influence of cytoskeleton organization on recombinant protein expression by CHO cells
por: Pourcel, Lucille, et al.
Publicado: (2020) -
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
por: Walker, Brian A, et al.
Publicado: (2013) -
Engineering death resistance in CHO cells for improved perfusion culture
por: MacDonald, Michael A., et al.
Publicado: (2022)